Back
Akero Therapeutics Vs. Progress Software Industry Stock Comparison
Buy
75
AKRO
Akero Therapeutics
Last Price:
23.45
Seasonality Move:
38.97%
Buy
77
PRGS
Progress Software
Last Price:
54.27
Seasonality Move:
6.23%
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $23.46. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Progress Software (PRGS)
is a Buy
Is Progress Software a Buy, Sell or Hold?
- The current Progress Software [PRGS] share price is $54.27. The Score for PRGS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- PRGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $23.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRGS Stock Price Chart
What is Progress Software's stock price today?
-
The Progress Software share price today is $54.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRGS is experiencing slight selling pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 57.52 | Buy |
| Chaikin Money Flow: | 2733533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.57 - 23.83) | Buy |
| Bollinger Bands (100): | (19.6 - 25.96) | Buy |
PRGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 67.87 | Buy |
| Chaikin Money Flow: | -280613 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.7 - 52) | Buy |
| Bollinger Bands (100): | (49.87 - 54.21) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.04 | Buy |
| 20-day SMA: | 22.45 | Buy |
| 50-day SMA: | 21.05 | Buy |
| 200-day SMA: | 23.46 | Buy |
| 8-day EMA: | 23.21 | Buy |
| 20-day EMA: | 22.53 | Buy |
| 50-day EMA: | 22.01 | Buy |
| 200-day EMA: | 25.3 | Sell |
PRGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.92 | Buy |
| 20-day SMA: | 50.43 | Buy |
| 50-day SMA: | 50.64 | Buy |
| 200-day SMA: | 53.07 | Buy |
| 8-day EMA: | 51.94 | Buy |
| 20-day EMA: | 50.91 | Buy |
| 50-day EMA: | 50.96 | Buy |
| 200-day EMA: | 52.88 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.83 per share, and a decrease next year of $0.65 per share.
Progress Software Earnings Growth & PRGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.16 per share, an increase this year of $0.51 per share, and an increase next year of $0.31 per share.
Akero Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Progress Software Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||